Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...

Results from a small retrospective analysis of patients with upper tract urothelial carcinoma lesions were shared at the 2025 ASCO Genitourinary Cancers Symposium.

Final results were consistent with previously conducted research in patients with advanced renal cell carcinoma treated with ...

GU ASCO annual meeting featured a urothelial carcinoma session and a discussant presentation by Dr. Scot Niglio discussing two abstracts: “Safety and efficacy of neoadjuvant immunotherapy with ...

Background: Abnormal extracellular matrix (ECM) remodeling plays an essential role in urothelial carcinoma (UC) invasiveness and metastasis ... had coexisting ureteral and renal pelvic tumors, and 62 ...

Dr. Axel Heidenreich presented the final results of the COTRIMS (Cologne trial of retroperitoneal lymphadenectomy in metastatic seminoma) trial. Clinical stage (CS) IIA/B seminoma accounts for only 10 ...

Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...

Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at Texas Tech University Health Sciences Center (TTUHSC) and director of the ...

Renal cell carcinoma (RCC) refers to a heterogenous group of cancers that originate in the proximal convoluted tubule of the kidney. The three most common forms of RCC are clear cell RCC ...

Advanced transitional-cell carcinoma of the bladder is the most ... Nevertheless, 40–50% of patients have impaired renal function that precludes the use of cisplatin. The non-nephrotoxic ...

Multiple therapeutic options are available for the management of patients with upper urinary tract transitional cell carcinoma (TCC ... baseline renal insufficiency, and significant comorbid ...